Despite its potential, the implementation of genetic engineering in epidemiology faces several challenges. These include technical limitations, high costs, and the need for rigorous testing to ensure the safety and efficacy of genetically engineered products. Additionally, public acceptance and understanding of genetic engineering technologies are crucial for their successful implementation.
